SOL Capital Management CO Has $604,000 Position in Monsanto Company (NYSE:MON)
SOL Capital Management CO lowered its stake in shares of Monsanto Company (NYSE:MON) by 3.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,100 shares of the basic materials company’s stock after selling 200 shares during the period. SOL Capital Management CO’s holdings in Monsanto were worth $604,000 as of its most recent filing with the SEC.
Other hedge funds have also modified their holdings of the company. First PREMIER Bank raised its stake in shares of Monsanto by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock valued at $102,000 after buying an additional 36 shares in the last quarter. Whitnell & Co. raised its stake in shares of Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. acquired a new stake in shares of Monsanto during the first quarter valued at approximately $113,000. Acrospire Investment Management LLC acquired a new stake in shares of Monsanto during the first quarter valued at approximately $113,000. Finally, JNBA Financial Advisors raised its stake in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares in the last quarter. Hedge funds and other institutional investors own 75.31% of the company’s stock.
Shares of Monsanto Company (NYSE:MON) traded down 0.24% during midday trading on Monday, reaching $117.56. The company’s stock had a trading volume of 354,473 shares. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97. The company has a 50 day moving average of $117.53 and a 200-day moving average of $114.70. The stock has a market capitalization of $51.65 billion, a price-to-earnings ratio of 25.39 and a beta of 1.07.
Monsanto (NYSE:MON) last posted its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. The company had revenue of $4.23 billion for the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. Monsanto’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the previous year, the business posted $2.17 earnings per share. Equities research analysts predict that Monsanto Company will post $4.89 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, July 7th were paid a $0.54 dividend. The ex-dividend date was Wednesday, July 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.83%. Monsanto’s dividend payout ratio is presently 46.75%.
TRADEMARK VIOLATION WARNING: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/07/sol-capital-management-co-has-604000-position-in-monsanto-company-nysemon.html.
Several analysts have recently commented on the company. Citigroup Inc. reiterated a “neutral” rating and set a $125.00 price objective (up previously from $122.00) on shares of Monsanto in a report on Friday, April 14th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price objective for the company in a report on Tuesday, June 27th. Barclays PLC increased their price objective on Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a report on Thursday, June 29th. Finally, Jefferies Group LLC downgraded Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a research report on Wednesday, July 12th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and eight have assigned a buy rating to the stock. Monsanto has a consensus rating of “Hold” and an average price target of $123.15.
In other Monsanto news, SVP Janet M. Holloway sold 7,423 shares of Monsanto stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $118.00, for a total value of $875,914.00. Following the transaction, the senior vice president now directly owns 33,645 shares in the company, valued at $3,970,110. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 74,470 shares of company stock worth $8,791,281. 0.79% of the stock is currently owned by company insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.